Health Care & Life Sciences » Pharmaceuticals | Biostar Pharmaceuticals Inc.

Biostar Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Sales/Revenue
49,317.80
52,729.10
61,416.60
27,129.60
2,384.50
Cost of Goods Sold (COGS) incl. D&A
19,466.80
27,046.20
31,140.20
16,025.50
1,469.30
Gross Income
29,851.00
25,682.80
30,276.40
11,104.10
915.20
SG&A Expense
41,991.80
24,934.50
28,971.30
30,082.90
4,479.40
EBIT
20,185.10
748.30
1,305.10
18,978.80
3,564.30
Unusual Expense
1,601.00
240.10
2,040.20
3,715.80
727.10
Non Operating Income/Expense
0.60
803.20
1,093.90
823.40
3.10
Interest Expense
84.40
-
154.50
283.60
206.20
Pretax Income
21,573.70
2,656.00
1,534.60
23,792.70
3,045.30
Income Tax
1,576.40
1,847.00
3,313.60
1,319.80
2,653.10
Consolidated Net Income
19,997.30
809.00
4,848.20
25,112.60
5,698.40
Net Income
19,997.30
809.00
4,848.20
25,112.60
5,698.40
Net Income After Extraordinaries
19,997.30
809.00
4,848.20
25,112.60
5,698.40
Net Income Available to Common
19,997.30
809.00
4,848.20
25,112.60
5,698.40
EPS (Basic)
2.09
0.06
0.33
1.63
2.50
Basic Shares Outstanding
9,570.90
13,509.50
14,499.40
15,477.20
2,297.30
EPS (Diluted)
2.09
0.06
0.33
1.62
2.48
Diluted Shares Outstanding
9,570.90
13,509.50
14,499.40
15,477.20
2,297.30
EBITDA
18,357.20
3,535.00
4,391.30
16,658.60
2,421.70
Other Operating Expense
8,044.30
-
-
-
-
Non-Operating Interest Income
296.10
1,344.60
1,330.30
8.90
1.20

About Biostar Pharmaceuticals

View Profile
Address
No. 588 Shiji Xi Avenue
Xianyang Shaanxi 712046
China
Employees -
Website http://www.biostarpharmaceuticals.com
Updated 07/08/2019
BioStar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of pharmaceutical and health supplement products for a variety of diseases and conditions. It's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting the Chinese population. The company was founded on March 27, 2007 and is headquartered in Xianyang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.